Home › Funds › venBio Partners LLC › DARE

venBio Partners LLC position in DARE

YARROW BIOSCIENCE INC · Health Care

venBio Partners LLC reported holding 554,769 shares of DARE (YARROW BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$12.5M, representing 2.52% of its reported portfolio and ranking #7 among its reported holdings. venBio Partners LLC first reported this position in Q3 2026.

Latest position (Q3 2026)554.77K sh
Reported value held$12.49M
Portfolio Weight2.52%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How venBio Partners LLC's DARE position evolved

venBio Partners LLC first disclosed a stake in DARE in Q3 2026 at 554,769 shares (US$12.5M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 554.77K $12.49M New

About DARE and 13F data

DARE (YARROW BIOSCIENCE INC) is a Health Care company. 56 other funds we track also report a position in DARE — the largest reported positions include Logos Global Management LP (US$23.1M), Bellevue Group AG (US$22.5M), PERCEPTIVE ADVISORS LLC (US$18.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DARE

All DARE fund holders →

FAQ

How long has venBio Partners LLC held DARE?

venBio Partners LLC has disclosed DARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is venBio Partners LLC's current position in DARE?

As of Q3 2026, venBio Partners LLC holds 554.77K shares of DARE (YARROW BIOSCIENCE INC), valued at $12.49M, representing 2.52% of its reported portfolio and ranking #7.

Has venBio Partners LLC been buying or selling DARE?

In the latest 13F filing (Q3 2026), venBio Partners LLC newly opened its position in DARE.

Which other funds hold DARE?

Other major institutional holders of DARE include Logos Global Management LP, Bellevue Group AG, PERCEPTIVE ADVISORS LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.